Mercato della cannula nasale ad alto flusso nell\'Asia-Pacifico fino al 2027: analisi regionale e previsioni per componente (miscelatore di ossigeno, cannula nasale, circuito inspiratorio riscaldato e umidificatore attivo); Applicazione (bronchiectasie, insufficienza respiratoria acuta, insufficienza cardiaca acuta e malattia polmonare ostruttiva cronica); Utente finale (centri di assistenza ambulatoriale, ospedali e centri di assistenza a lungo termine) e Paese
Si prevede che il mercato delle cannule nasali ad alto flusso nell\'area Asia-Pacifico
raggiungerà 2.536,52 milioni di dollari nel 2027 da 951,53 milioni di dollari nel 2018. Si prevede che il mercato crescerà con un CAGR dell\'11,7% nel periodo 2019-2027.
I fattori chiave che stanno guidando la crescita del mercato delle cannule nasali ad alto flusso sono la crescente popolazione anziana e l’aumento delle malattie respiratorie croniche nell’area APAC. Tuttavia, i fattori che frenano la crescita del mercato sono gli effetti collaterali associati alla cannula nasale ad alto flusso.
Secondo l\'Alleanza NCD, le malattie respiratorie croniche Le malattie (CRD) descrivono una serie di malattie delle vie aeree e delle altre strutture dei polmoni. Asma e allergie respiratorie, malattie polmonari professionali, broncopneumopatia cronica ostruttiva (BPCO), sindrome dell\'apnea notturna e ipertensione polmonare sono solo alcune di queste. Il peso delle malattie respiratorie croniche (CRD) è in aumento in tutti i paesi dell’Asia-Pacifico. Secondo l\'articolo pubblicato su The Lancet Global Health, l\'India ha il 18% della popolazione mondiale e un carico crescente di malattie respiratorie croniche.
\' span>
La prevalenza dell\'asma in India è significativamente elevata rispetto ad altri paesi. Con circa 15-20 milioni di pazienti asmatici, almeno un paziente asmatico su dieci vive in India. Secondo le stime dell’OMS, circa 30 milioni di indiani soffrono di asma. Alcuni dei fattori comuni per l’aumento del numero di casi di asma in India includono, tra gli altri, l’obesità, il fumo, l’inquinamento dell’aria interna ed esterna, l’improvviso uso eccessivo o improprio di antibiotici, pollini, fumo passivo, case e luoghi di lavoro scarsamente ventilati. . Oltre all’asma, l’aumento dei casi di BPCO è motivo di preoccupazione nel paese. Secondo lo studio Global Burden of Disease del 2018 dell\'Università di Washington, la BPCO è stata la seconda causa di morte in India, provocando la morte di quasi 958.000 persone.
< /p>
Entrate e previsioni del mercato indiano delle cannule nasali ad alto flusso fino al 2027 (milioni di dollari)
Mercato europeo delle cannule nasali ad alto flusso - Per componente
Miscelatore di aria e ossigeno
Cannula nasale
Circuito inspiratorio riscaldato
Umidificatore attivo
Europa ad alto flusso Mercato delle cannule nasali - Per applicazione
Bronchiectasie
Insufficienza respiratoria acuta
< li>Insufficienza cardiaca acuta
Malattia polmonare ostruttiva cronica (BPCO)
Mercato europeo delle cannule nasali ad alto flusso - Per utente finale
Ospedali
Centri di cura ambulatoriali
Centri di assistenza a lungo termine
Mercato europeo delle cannule nasali ad alto flusso
Strategic insights for Asia-Pacific High-Flow Nasal Cannula involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
The regional scope of Asia-Pacific High-Flow Nasal Cannula refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Asia-Pacific High-Flow Nasal Cannula Market
The List of Companies - APAC High Flow Nasal Cannula Market
Great Group Medical Co., Ltd.
Salter Labs
Fisher And Paykel Healthcare Limited
TNI Medical Ag
Mek-Ics Co., Ltd.
Flexicare Medical Limited
Vapotherm
Teleflex Incorporated
Resmed
Hamilton Medical Inc,
Frequently Asked Questions
How big is the Asia-Pacific High-Flow Nasal Cannula Market?
The Asia-Pacific High-Flow Nasal Cannula Market is valued at US$ 951.53 Million in 2018, it is projected to reach US$ 2,536.52 Million by 2027.
What is the CAGR for Asia-Pacific High-Flow Nasal Cannula Market by (2019 - 2027)?
As per our report Asia-Pacific High-Flow Nasal Cannula Market, the market size is valued at US$ 951.53 Million in 2018, projecting it to reach US$ 2,536.52 Million by 2027. This translates to a CAGR of approximately 11.7% during the forecast period.
What segments are covered in this report?
The Asia-Pacific High-Flow Nasal Cannula Market report typically cover these key segments-
Utente finale (centri di assistenza ambulatoriale, ospedali e centri di assistenza a lungo termine)
What is the historic period, base year, and forecast period taken for Asia-Pacific High-Flow Nasal Cannula Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific High-Flow Nasal Cannula Market report:
Historic Period : 2016-2017
Base Year : 2018
Forecast Period : 2019-2027
Who are the major players in Asia-Pacific High-Flow Nasal Cannula Market?
The Asia-Pacific High-Flow Nasal Cannula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Great Group Medical Co., Ltd.
Salter Labs
Fisher And Paykel Healthcare Limited
TNI Medical Ag
Mek-Ics Co., Ltd.
Flexicare Medical Limited
Vapotherm
Teleflex Incorporated
Resmed
Hamilton Medical Inc,
Who should buy this report?
The Asia-Pacific High-Flow Nasal Cannula Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Asia-Pacific High-Flow Nasal Cannula Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Asia-Pacific High-Flow Nasal Cannula Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines
Get Free Sample For Asia-Pacific High-Flow Nasal Cannula Market
